World Sight Foundation Field Machine pilot in glaucoma care
Official title: Clinical Testing Pilot of the World Sight Foundation Field Machine (WSFFM) in Glaucoma Patients - Comparison With Humphrey Visual Field Analyser
Run by Buckinghamshire Healthcare NHS Trust · NCT07674069 · Data updated 2026-11-12
This pilot tests a new field machine to see if it can help identify moderate to severe glaucoma in patients at a eye clinic, compared with the standard Humphrey Visual Field test.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 99 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Buckinghamshire Healthcare NHS Trust Academic / other |
| Locations | 1 site (Aylesbury) |
| Status | Recruiting |
| Started | April 29, 2026 |
| Main results expected | July 1, 2026 |
| Study ends | July 1, 2026 |
| Registry record updated | June 29, 2026 |
| Trial ID | NCT07674069 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 years or older attending a glaucoma outpatient clinic who require visual field testing using HVF standard protocols.
✕Probably not a fit
Patients who do not require visual field testing during their visit or who are unable to perform the test may derive no direct benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This exploratory pilot study evaluates how well the World Sight Foundation Field Machine performs in identifying moderate to severe visual field loss among glaucoma patients at a single NHS clinic. It compares WSFFM to the gold-standard HVF analyser, acknowledging it is not expected to be equivalent or non-inferior, but to provide insight into the device’s potential role in resource-limited settings. Participants are adults attending the glaucoma outpatient service who require visual field testing, and the study integrates into routine clinic activities with no additional follow-up beyond the trial visit. The trial seeks to understand practical use, feasibility, and performance in real-world conditions to inform future implementation in lower-income regions. Data will focus on how well WSFFM identifies significant field loss relative to HVF in this setting.
Why it matters
Potential benefit: If successful, WSFFM could offer a practical tool to help clinicians detect meaningful vision loss in glaucoma earlier, potentially guiding timely treatment or referrals.
How similar studies have gone: Previous work has explored field testing devices in glaucoma, but this pilot focuses on a novel device in a real-world, low-resource setting and is not designed to establish equivalence with HVF.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * \- Patients attending glaucoma outpatient clinic * Patients requiring visual field testing, with plan for "SITA-STANDARD" HVF testing * Patients 18 years or older and of any gender * Patients capable of giving informed consent. Exclusion Criteria: * \- Patients not requiring visual field testing on that outpatient clinic attendance. * Patients requiring visual field testing, with plan for "SITA-FAST" or "SITA-FASTER" HVF testing. * Patients who do not attend their outpatient clinic appointment, * Patients not able to perform visual field testing (for example due to their visual acuity, physical difficulty in positioning for test duration, or cognitive difficulties in understanding instructions). * Patients under the age of 18 years old.
Where it's running
-
Buckinghamshire Healthcare NHS Trust
Aylesbury, United Kingdom Recruiting
Study contacts
- Study coordinator: James Cooper
- Email: james.cooper9@nhs.net
- Phone: 07816020305
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Balance training for people with glaucoma
A randomized study tests whether a structured eight-week balance program helps adults with glaucoma improve balance, reduce fall risk, and lessen fear of falling.
-
Eye drops Rhopressa vs Timolol to protect nerve cells in glaucoma
In adults with open-angle glaucoma, this study tests whether Rhopressa helps preserve retinal nerve cells better than Timolol while both lower eye pressure.
-
Comparison of FT-1000 non-contact tonometry with Goldmann applanation tonometry in glaucoma patients
This study tests whether the FT-1000 non-contact tonometer gives measurements that agree with the Goldmann applanation tonometer in adults with glaucoma.
-
Removing the ripcord from a glaucoma drainage device after 3 months
This study tests whether removing the ripcord from an implanted glaucoma drainage device changes eye pressure for adults with open-angle glaucoma.
-
Glaucoma and Brain Changes: How Brain Structure and Size See What Glaucoma Is Doing
This study tests whether glaucoma is linked to broader brain changes by comparing brain MRI and eye health over time in people with glaucoma and matched controls.
-
Long-Term Results After Ab-interno Trabeculotomy for Glaucoma
This study tests whether ab-interno trabeculotomy with the Trabectome can provide sustained intraocular pressure reduction in glaucoma patients who had the procedure between 2019 and 2021.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.